These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy. Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299 [TBL] [Abstract][Full Text] [Related]
3. [The characteristics of 123I-MIBG myocardial scintigraphy in patients with left ventricular pressure-overload diseases]. Kobayashi H; Momose M; Niki K; Yamazumi R; Iguchi N; Inoue S; Horie T; Kusakabe K; Hosoda S Kaku Igaku; 1995 Jun; 32(6):587-92. PubMed ID: 7674569 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy. Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Nakajima K; Taki J; Mabuchi H J Nucl Med; 2002 Jan; 43(1):15-20. PubMed ID: 11801697 [TBL] [Abstract][Full Text] [Related]
5. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy]. Narita M; Kurihara T J Cardiol; 1996 Mar; 27(3):133-41. PubMed ID: 8865685 [TBL] [Abstract][Full Text] [Related]
6. Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function. Pace L; Betocchi S; Losi MA; Della Morte AM; Ciampi Q; Nugnez R; Chiariello M; Salvatore M Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):20-5. PubMed ID: 15195000 [TBL] [Abstract][Full Text] [Related]
7. Increased QT dispersion does not reflect the increased regional variation of cardiac sympathetic nervous activity in hypertrophic cardiomyopathy. Shimizu M; Ino H; Okeie K; Yamaguchi M; Hayashi K; Nagata M; Itoh H; Iwaki T; Oe K; Konno T; Taki J; Nakajima K; Mabuchi H Am Heart J; 2001 Aug; 142(2):358-62. PubMed ID: 11479478 [TBL] [Abstract][Full Text] [Related]
8. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT. Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621 [TBL] [Abstract][Full Text] [Related]
9. Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy. Matsuo S; Nakamura Y; Tsutamoto T; Kinoshita M J Nucl Cardiol; 2002; 9(4):407-12. PubMed ID: 12161717 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of hypertrophic cardiomyopathy with 123I-metaiodobenzylguanidine]. Nakajima K; Bunko H; Taki J; Shimizu M; Nanbu I; Muramori A; Matsunari I; Hisada K Kaku Igaku; 1990 Jan; 27(1):33-8. PubMed ID: 2338765 [TBL] [Abstract][Full Text] [Related]
12. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy. Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475 [TBL] [Abstract][Full Text] [Related]
13. [Two patients with hypertrophic cardiomyopathy showing regionally increased washout of 123I-MIBG from the thick myocardium]. Yoshimura N; Kimura M; Ozaki T; Takahashi N; Sakai K Kaku Igaku; 1998 Jun; 35(5):315-20. PubMed ID: 9695464 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of I-123 MIBG myocardial scintigraphy for evaluating the severity of congestive heart failure]. Morozumi T; Ishida Y; Tani A; Sato H; Matsuyama T; Ozaki H; Hori M; Kitabatake A; Kamada T; Kimura K Kaku Igaku; 1991 Mar; 28(3):271-80. PubMed ID: 2046182 [TBL] [Abstract][Full Text] [Related]
15. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure]. Narita M; Kurihara T; Murano K; Usami M; Honda M Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231 [TBL] [Abstract][Full Text] [Related]
16. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP]. Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis]. Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689 [TBL] [Abstract][Full Text] [Related]
18. Iodine-123 metaiodobenzylguanidine imaging can predict future cardiac events in Japanese patients with Parkinson's disease. Kinbara T; Hayano T; Otani N; Furutani Y; Tanaka S Ann Nucl Med; 2013 Feb; 27(2):123-31. PubMed ID: 23086545 [TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. Nakajima K; Bunko H; Taki J; Shimizu M; Muramori A; Hisada K Am Heart J; 1990 Jun; 119(6):1329-37. PubMed ID: 2353619 [TBL] [Abstract][Full Text] [Related]
20. Clinical relationship of myocardial sympathetic nervous activity to cardiovascular functions in chronic heart failure: assessment by myocardial scintigraphy with 123I-metaiodobenzylguanidine. Wada Y; Miura M; Fujiwara S; Mori S; Seiji K; Kimura T Tohoku J Exp Med; 2003 Dec; 201(4):261-70. PubMed ID: 14690018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]